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Summary Epidemiological evidence suggests that breastfeeding protects against breast cancer. Whether an effect of age at first
breastfeeding is independent of an effect of age at first birth is unclear. We hypothesized that nausea and vomiting in pregnancy, which are
associated with elevated serum oestradiol levels during pregnancy, may increase risk. Cases were 452 parous, premenopausal women, 40
years or younger, diagnosed with breast cancer in Los Angeles County from July 1983 to December 1988. Control subjects were matched to
cases on age, race, parity and neighbourhood. Pregnancy and breastfeeding histories were obtained from in-person interviews. Odds of breast
cancer among women who breastfed for at least 16 months relative to those among women who did not breastfeed was 0.66 [95% confidence
interval (Cl) 0.41-1.05]. Number of children breastfed was not associated with risk. Risk was lower in women who first breastfed at older ages.
Having ever been treated for nausea or vomiting during pregnancy was associated with an increased risk, especially in women experiencing
recent pregnancies (OR = 2.03, 95% Cl 1.05-3.92). These results support a protective role of breastfeeding and an adverse role of nausea or
vomiting during pregnancy in the development of premenopausal breast cancer, especially in the years immediately following pregnancy.
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Although the role of breastfeeding in the development of breast
cancerhas been examined in many studies dating back to the early
1970s, several important issues remain unresolved. Two recent
studies suggested that age at first breastfeeding modifies the
protective association ofduration ofbreastfeeding on the develop-
ment of premenopausal breast cancer (Newcomb et al, 1994;
Brinton et al, 1995), but it is unclear whether the observed protec-
tive association of young age at first breastfeeding is independent
of an effect of young age at first birth. Whether the protective
effect of breastfeeding is modified by the number of children
breastfed is also unresolved.
Previously we found that extreme nausea and vomiting ofpreg-
nancy is associated with higher levels of serum oestradiol in early
pregnancy (Depue et al, 1987). Based on this finding, we hypothe-
sized that breast cancer risk might be elevated in women who
experienced nausea and vomiting in pregnancy, supporting a role
for ovarian steroid hormones in the development ofbreast cancer.
To clarify these issues, we examined data from a population-
based case-control study of breast cancer in young, white and
Hispanic premenopausal women in Los Angeles County.
METHODS
The design of this breast cancer case-control study has been
described in detail elsewhere (Bernstein et al, 1994). Eligible
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subjects included all white (including Hispanic), English-
speaking, female residents of Los Angeles County, born in the
United States, Canada orWestern Europe, with no history ofbreast
cancer. Eligible case subjects were aged 40 years or younger, and
were diagnosed for the first time with in situ or invasive breast
cancer between 1 July 1983 and 1 January 1989. Case subjects
were identified by the University of Southern California Cancer
Surveillance Program, the population-based cancer registry for
Los Angeles County. One neighbourhood control subject was indi-
vidually matched to each case subject on birthdate (within 3
years), parity (nulliparous vs parous), and neighbourhood.
Of 969 eligible case subjects, 949 (97.9%) were alive when
theirphysicians were asked forpermission to contact them. Of949
living eligible case subjects, 744 (76.8%) completed the interview.
Of the 205 eligible case subjects who did not participate, the
physician refused to allow contact with 54 (5.6% of identified
patients), seven (< 1%) could not be interviewed because of
mental or physical health problems, 111 (11.5%) refused to be
interviewed, 12 (1.2%) had moved out ofLos Angeles County and
could not be interviewed in person and 21 (2.2%) were lost to
follow-up.
Controls were selected from housing units in a predefined walk
pattern in the neighbourhood where the case subject lived at the
time of her diagnosis with breast cancer. For each housing unit in
the walk pattern, we identified women who matched the case on
all relevant characteristics. When no-one was home, we made
repeated attempts to obtain the information by telephone or mail.
We canvassed a median of 32 housing units per eligible control
that we interviewed. We identified more than 25% of the eligible
controls after canvassing 12 or fewerhousing units, and 75% were
identified after canvassing 82 units. For 592 breast cancer patients
(80%), the first eligible control subject participated. For 124
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Table 1 Multivariate odds ratios (OR) for selected breast cancer risk factors
among parous, premenopausal women, ages 40 years or younger (n = 452
matched pairs).
Variable Cases Controls ORa (95% CIb)
Age at first full-term pregnancy
< 20 100 114 1
20-24 158 170 1.07 (0.72-1.59)
25-29 128 104 1.47 (0.95-2.27)
.30 66 64 1.15 (0.67-1.99)
Trend P 0.23
Number of full-term pregnanciesc
1 140 131 1
2 207 188 1.08 (0.75-1.54)
.3 105 133 0.77 (0.51-1.19)
Trend P 0.24
Age at menarche
< 12 131 107 1
12 124 117 0.87 (0.59-1.27)
13 127 130 0.74 (0.51-1.08)
2 14 70 98 0.59 (0.39-0.91)
Trend P 0.01
Family history of breast cancerd
No 378 412 1
Yes 65 28 2.54 (1.57-4.11)
Unknown 9 12 0.73 (0.29-1.88)
Months of oral contraceptive use
0 65 67 1
1-48 238 248 0.95 (0.64-1.43)
60-119 103 104 0.87 (0.55-1.39)
. 120 46 33 1.35 (0.75-2.44)
Trend P 0.61
aResults from multivariate model that included all variables in Table 1 and
average alcohol consumption per week and average hours per week of
physical activity during reproductive years. bCl = confidence interval.
clncludes live and still births. dIncludes only first-degree relatives (mother
and sisters).
patients, the second eligible control subject participated after the
first refused. For 18 patients, the third eligible control subject
participated; for four patients, the fourth eligible control subject
participated; for four patients, the fifth eligible control subject
participated; and for two patients, the seventh eligible control
subject participated. Complete censuses were obtained in the walk
patterns for neighbourhoods of223 case subjects.
In-person interviews, averaging 45 min in length, were
conducted in the subjects' homes by the same female nurse-inter-
viewer. A reference date was created for each subject. For each
case-control pair, the reference date was the date that was 12
months prior to the index patient's breast cancer diagnosis. We
obtained complete reproductive and breastfeeding histories, as
well as detailed information on other potential breast cancer risk
factors including use of oral contraceptives, family history of
cancer, physical activity habits and alcohol consumption patterns
prior to the reference date. Family history of breast cancer was
considered to be positive ifthe subject had a mother or sister who
had been diagnosed with breast cancer.
For each pregnancy, we obtained the following information:
month and year pregnancy ended, outcome (current pregnancy,
single or multiple live birth, stillbirth, spontaneous miscarriage,
induced abortion, tubal pregnancy), gestation (months), treatment
with drugs or hospitalization for nausea or vomiting during preg-
nancy (yes/no), treatment with hormones to induce or promote
Table 2 Odds ratios (OR) for breast cancer according to breastfeeding
experience among parous, premenopausal women, ages 40 years or
younger.
Variable Cases Controls ORa ORb (95% Cl)
History of breastfeeding
Never 190
Ever 262
Lifetime months of breastfeeding
0 190
1-6
7-15
. 16
Trend P
Number of children breastfed
None
1
2
>3
Trend P
129
83
50
180 1.00 1.00
272 0.90 0.93 (0.69-1.26)
180
107
90
75
180
136
93
43
190
130
98
34
Lifetime months ofbreasffeedingd
Number of full-term pregnancies = 1
0 67
1-6 45
7-15 22
> 16
Trend P
6
Number of full-term pregnancies 2 2
0 123
1-6 84
7-15
> 16
Trend P
61
44
47
41
31
12
133
66
59
63
Lifetime months ofbreasifeeding
Most recent full-term pregnancy < 5 years ago
0 45 24
1-6 38 30
7-15 27 50
.16 24 37
Trend P
Most recent full-term pregnancy 2 5 years ago
0 145 156
1-6 91 77
7-15 56 40
.16 26 38
Trend P
1.00
1.14
0.86
0.64
0.03
1.00
0.90
1.00
0.74
0.42
1.00
0.77
0.50
0.35
0.02
1.00
1.38
1.12
0.76
0.13
1.00
0.68
0.29
0.35
0.003
1.00
1.27
1.51
0.74
0.46
1.00
1.15 (0.80-1.65)
0.84 (0.56-1.27)
0.66 (0.41-1.05)
0.04
1.00
0.87 (0.61-1.25)
1.05(0.70-1.57)
0.90 (0.50-1.63)
0.85
1.00
0.77 (0.41-1.47)
0.51 (0.23-1.09)
0.33 (0.11-1.05)
0.04
1.00
1.36 (0.89-2.07)
1.09 (0.69-1.72)
0.77 (0.47-1.27)
0.19
1.00
0.71 (0.34-1.50)
0.29 (0.14-0.61)
0.30 (0.14-0.65)
0.002
1.00
1.32 (0.88-1.96)
1.55 (0.93-2.59)
0.85 (0.46-1.56)
0.73
aUnivariate model. bMultivariate model included age at first full-term
pregnancy, number of full-term pregnancies, age at menarche, first degree
family history of breast cancer, lifetime months of oral contraceptive use,
race, average alcohol consumption perweek, and average hours per week of
physical activity during reproductive years. CCI = confidence interval.
dMultivariate models included all covariates in footnote b except number of
full-term pregnancies.
labour (yes/no), treatment with hormones to suppress lactation
(yes/no) and months breastfed.
Of 744 matched pairs, 292 were dropped from the analysis
because the women were nulliparous (274 pairs) or because at
least one of the women was no longer menstruating (18 pairs),
resulting in 452 parous, premenopausal case-control pairs. Odds
ratios (ORs) and 95% confidence intervals (95% CIs) were calcu-
lated using conditional logistic regression methods. Covariates
included in the multivariate model results presented were age at
first full-term pregnancy, number of full-term pregnancies, age at
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Table 3 Odds ratios for breast cancer according to age at first breasffeeding
experience among parous, premenopausal women, ages 40 years or
younger
Variable Cases Controls ORa ORb (95% Clc)
Age breastfed first child
Never breastfedd 190 180 1.00 1.00
<20 31 31 0.94 1.07 (0.58-1.97)
20-24 77 77 0.94 1.07 (0.72-1.60)
25-29 93 93 0.94 0.96 (0.65-1.41)
> 30 61 71 0.79 0.78 (0.50-1.24)
Trend Fa 0.70 0.53
Lifetime months ofbreastfeeding
Age at first breastfeeding < 25 years
1-6 51 43 1.12 1.34 (0.83-2.16)
7-15 36 32 1.07 1.23 (0.72-2.11)
>16 21 33 0.60 0.76 (0.41-1.39)
Trend pe 0.07 0.14
Age at first breastfeeding > 25 years
1-6 78 64 1.16 1.03 (0.67-1.58)
7-15 47 58 0.77 0.66 (0.40-1.08)
>16 29 42 0.65 0.55 (0.31-0.97)
Trend Pe 0.06 0.04
aUnivariate model. bMultivariate model included number of full-term
pregnancies, age at menarche, first degree family history of breast cancer,
lifetime months of oral contraceptive use, race, average alcohol consumption
per week, and average hours per week of physical activity during
reproductive years. cConfidence interval. dReference group for all variables.
eTrend Pbased on model that included only subjects who had ever
breastfed. 'Multivariate model included all covariates in footnote a except
number of full-term pregnancies.
menarche, months of use of oral contraceptives, average number
of drinks of alcohol per week at the reference date and average
hours per week of physical activity during reproductive years as
continuous variables, and first degree family history of breast
cancer (yes, no) and race (white, Hispanic) as categorical vari-
ables. Seven per cent of the case subjects and 5% of the control
subjects were Hispanic. One subject had missing data for the vari-
able 'Ever treated for nausea or vomiting during pregnancy'; eight
subjects had missing data for the variable 'Hormones given to
suppress lactation' and two subjects had missing data for the vari-
able 'Hormones given to induce or promote labour'. For each of
these variables the missing subjects were assigned to the category
'Never' or 'No'. Exclusion of these matched pairs from the data
set did not alter the results presented here. Because lifetime histo-
ries of physical activity were not collected from 122 case-control
pairs, these subjects were arbitrarily assigned values of0 for phys-
ical activity, which makes these matched pairs non-informative for
physical activity, but allows them to contribute to the analysis of
other risk factors. To test for trend in effect across categories, we
used the two-sided P-value associated with the slope coefficient fit
to the median value ofeach category ofthe variable.
RESULTS
On average, case subjects were slightly older than controls at first
full-term pregnancy; they had fewer full-term pregnancies; and
they were younger at their first menstrual period (Table 1). Case
subjects were more likely to have had a first-degree family history
of breast cancer than control subjects. In addition, compared with
controls, case subjects, on average, used oral contraceptives
slightly longer (Table 1), exercised less (Bernstein et al, 1994) and
consumed more alcohol (not shown).
Overall, having ever breastfed a child did not confer substantial
protection against the development of premenopausal breast
cancer in this study (Table 2), with 58% of cases and 60% of
controls having ever breastfed a child. However, because protec-
tion may only be observed among women who breastfeed for
many months or who breastfeed several children, lifetime months
of breastfeeding and number of children breastfed were also eval-
uated. Women who breastfed for 16 months or longer were at a
substantially reduced risk of developing breast cancer compared
with women who never breastfed, and adjusting for other breast
cancer risk factors did not markedly change this association (Table
2). The number of children breastfed was not clearly associated
with breast cancer risk.
We evaluated whether total duration ofbreastfeeding was modi-
fied by number offull-term pregnancies (Table 2). Longer lifetime
duration of breastfeeding was clearly associated with reduced
breast cancer risk among women with only one full-term preg-
nancy, but the association was more modest among women who
had two or more full-term pregnancies. Because the small protec-
tion among women who had two or more full-term pregnancies
may be due to the effect of breastfeeding after the first pregnancy,
we analysed duration of breastfeeding after the first pregnancy
separately from duration of breastfeeding after the second and
subsequent pregnancies among women with two or more full-term
pregnancies. In this group of multiparous women, duration of
breastfeeding after the first pregnancy was not associated with
breast cancer risk (. 8 months of breastfeeding compared with
never breastfeeding: multivariate OR = 1.24, 95% CI 0.72-2.14).
However, longer durations of breastfeeding following the second
and subsequent pregnancies were associated with slightly reduced
breast cancer risk (. 8 months breastfeeding: multivariate OR =
0.72, 95% CI 0.46-1.13).
Although the long-term effect of pregnancy is clearly to reduce
breast cancerrisk, there is a hypothesized dual effect ofpregnancy
on risk: a transient increase in risk for roughly three years
following the pregnancy, followed by a long-term reduction in risk
(Woods et al, 1980; Bruzzi et al, 1988; Adami et al, 1990;
Williams et al, 1990; Vatten and Kvinnsland 1992; Cummings et
al, 1994; Hsieh et al, 1994; Lambe et al, 1994; Albrektsen et al,
1995; Leon et al, 1995). Because the women in this study were
premenopausal and may have experienced a recent pregnancy, we
analysed the breastfeeding-breast cancer association separately for
women whose most recent full-term pregnancy was within 5 years
of their breast cancer diagnosis (or within 5 years of the case's
diagnosis for controls) and for women whose most recent full-term
pregnancy was 5 years or more before the date ofdiagnosis (Table
2). Breast cancer risk was substantially reduced with longer dura-
tions of breastfeeding among women who had experienced recent
full-term pregnancies, but not among women whose most recent
full-term pregnancy occurred in the distant past.
We evaluated the effect of age at first breastfeeding on breast
cancer risk (Table 3). Risk appeared to decrease slightly with
increasing age at first breastfeeding. We analysed lifetime duration
ofbreastfeeding separately for women who were less than 25 years
compared with older women when they breastfed for the first time
(Table 3). Number of full-term pregnancies was not included in
this analysis because very few of the younger women who
breastfed for long durations experienced fewer than two full-term
pregnancies, so that their inclusion would have produced unstable
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Table 4 Odds ratios (OR) for breast cancer according to other pregnancy or
childbirth experiences among parous, premenopausal women, ages 40 years
or younger
Variable Cases Controls ORa ORb (95% Cl-)
Treatment fornausea or vomiting during anypregnancyd
All women
No 326 343 1.00
Yes 126 109 1.22
P 0.19
1.00
1.40 (1.01-1.95)
0.04
Women whose most recent full-term pregnancy was < 5 years ago
No 99 118 1.00 1.00
Yes 35 23 1.81 2.03 (1.05-3.92)
P 0.05 0.04
Women whose most recent full-term pregnancy was . 5 years ago
No 227 225 1.00 1.00
Yes 91 86 1.05 1.18 (0.81-1.71)
P 0.79 0.39
Lifetime months ofbreasffeedinge
Never treated for nausea or vomiting of pregnancy
0 139 134
1-3 98 82
4-7 59 69
.8 30 58
Trend P
Ever treated for nausea or vomiting of pregnancy
0 51 46
1-3 31 25
4-7 24 21
.8 20 17
Trend P
Hormones given to suppress lactation
Never 240
Once 109
Twice or more 103
Trend P
245
107
100
Hormones given to induce or promote labour
Never 277 278
Ever 175 174
p
1.00 1.00
1.15 1.17 (0.78-1.75)
0.82 0.92 (0.58-1.47)
0.50 0.58 (0.33-1.02)
0.002 0.035
1.00 1.00
1.12 1.14 (0.56-2.29)
1.03 0.91 (0.41-1.99)
1.06 1.05 (0.44-2.51)
0.93 0.98
1.00 1.00
1.04 0.96 (0.66-1.39)
1.05 1.07 (0.69-1.67)
0.74 0.81
1.00 1.00
1.01 1.04 (0.77-1.40)
0.95 0.79
aUnivariate model. bMultivariate model included age at first full-term
pregnancy, number of full-term pregnancies, lifetime months of
breastfeeding, age at menarche, first degree family history of breast cancer,
lifetime months of oral contraceptive use, race, average alcohol consumption
per week, and average hours per week of physical activity during
reproductive years. CCI = confidence interval. dAli pregnancies treated for
nausea or vomiting were full term; treatments included use of drugs and/or
hospitalization. eModel includes all variables in footnote b except lifetime
months of breastfeeding.
estimates. The protective association of duration of breastfeeding
with breast cancer risk was substantially greater among women
who were older than among women who were younger when they
first breastfed.
We analysed age atfirst breastfeeding separately forwomen who
breastfed their first child from women who first breastfed a later
child. Among women who breastfed their first child, there was no
association of age at first breastfeeding with breast cancer risk
(< 20 years ofage compared with neverbreastfeeding (multivariate
OR = 1.01, 95% CI 0.55-11.83; 2 30 years of age compared with
never breastfeeding, multivariate OR = 1.01, 95% CI 0.62-1.65;
trend P = 0.73 (trend test restricted to women who breastfed)).
Among women who first breastfed a later child breast cancer risk
decreased slightly with increasing age at first breastfeeding (< 20
years ofage, multivariate OR = 1.38, 95% CI 0.20-9.69; .30 years
ofage, multivariate OR = 0.82, 95% CI 0.37-1.81; trendP = 0.58).
The association oflifetime duration ofbreastfeeding with breast
cancer risk was weakly modified by age at menarche (P for inter-
action = 0.10) and first-degree family history of breast cancer (P
for interaction = 0.08). Lifetime duration ofbreastfeeding was not
associated with breast cancer risk among women with menarche
below age 13 years (> 16 months of breastfeeding, multivariate
OR = 1.17, 95% CI 0.62-2.21). However, among women with
menarche at 13 years or older, breast cancer risk was decreased
substantially with increasing duration of breastfeeding (2 16
months of breastfeeding, multivariate OR = 0.33, 95% CI
0.16-0.68). Although the number of women with a first-degree
family history ofbreast cancer who also breastfed was too small to
explore the breastfeeding-breast cancer association in a multi-
variate analysis, a univariate analysis revealed no duration effect
(2 16 months ofbreastfeeding compared with never breastfeeding,
OR = 1.25, 95% CI 0.36-4.37). Among women with no first-
degree family history of breast cancer, the association of lifetime
duration ofbreastfeeding with breast cancer risk was similar to the
results for all women combined (2 16 months of breastfeeding,
multivariate OR = 0.62, 95% CI 0.38-1.02). No evidence ofeffect
modification by physical activity or years oforal contraceptive use
on breast cancer risk was observed.
In a multivariate analysis, we found that women who had been
treated for nausea or vomiting of pregnancy with drugs or hospi-
talization were at increased breast cancer riskcompared with those
who had not been so treated (Table 4). These results did not vary
by age at first full-term pregnancy (not shown). We analysed the
association of treatment for nausea or vomiting ofpregnancy with
breast cancer separately for women with a full-term pregnancy
within the past 5 years and for those with a more distant pregnancy
(Table 4). Among women with recent full-term pregnancy, the
breast cancer risk was twofold higher for women who had been
treated for nausea or vomiting of pregnancy than for women who
had not been so treated. The association was greatly reduced
among women who did not experience a recent full-term preg-
nancy. Breastfeeding did not reduce breast cancer risk of women
who were treated for nausea or vomiting of pregnancy, but it
substantially reduced the risk of women who were not treated for
these conditions (Table 4). The findings were the same when the
analysis was restricted to women who gave birth within 5 years of
diagnosis (not shown).
Breast cancer risk was not associated with use of hormones to
suppress lactation or exposure to hormones to induce or promote
labour (Table 4).
Excluding pairs that included a patient with in situ breast cancer
(n = 40 matched pairs) did not substantially affect the results
presented (not shown).
DISCUSSION
In this group of young, premenopausal women, longer duration of
breastfeeding was associated with reduced breast cancer risk.
Number of children breastfed was unassociated with risk,
suggesting that the total duration ofbreastfeeding is most relevant
to protection. These results are consistent with the results of other
studies (Byers et al, 1985; Katsouyanni et al, 1986; McTieman and
Thomas, 1986; Rosero-Bixby et al, 1987; Tao et al, 1988; Yuan et
al, 1988; Layde et al, 1989; Wang et al, 1992; Yoo et al, 1992; UK
National CC Study Group, 1993; Yang et al, 1993; Newcomb et al,
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1994; Brinton et al, 1995; Romieu et al, 1996) which generally
found modest protection from breast cancer with long duration of
breastfeeding, especially among premenopausal women.
This protective effect of longer duration of breastfeeding was
greater among women who had experienced one full-term preg-
nancy than among women who had experienced two or more full-
term pregnancies. We thought it important from a public health
perspective to determine whether the small protection observed
among women with two or more full-term pregnancies was actu-
ally due to the protective effect ofbreastfeeding during a woman's
first pregnancy. Breast cancer risk was moderately reduced among
women who breastfed for 8 months or more following their second
or subsequent pregnancies, suggesting that the protective effect of
increased duration of breastfeeding is not restricted to the first
pregnancy.
Breast stem cells differentiate during the first full-term preg-
nancy and first lactation rendering them less susceptible to carcino-
genesis (Russo et al, 1982). However, unlike the findings of two
recent studies (Newcomb et al, 1994; Brinton et al, 1995) age at
first breastfeeding did not substantially modify the breast
cancer-breastfeeding relationship. In fact, contrary to these studies,
the protective association of duration of breastfeeding with breast
cancer risk was greater among women who breastfed for the first
time at older ages than among women who breastfed for the first
time at younger ages. However, we have discussed the difficulty in
determining whether any observed association ofage at first breast-
feeding is independent of an effect of age at first birth (Ross and
Yu, 1994). We attempted to address this issue by evaluating risk by
age at first breastfeeding for women who breastfed their first child
separately compared with women who only breastfed a later child.
Among women who breastfed their first child, age at first breast-
feeding had no effect on breast cancer risk. The small, but statisti-
cally significant, decrease in risk with increasing age at first
breastfeeding among women who breastfed only children born
after their first child may indicate some independent effect on
breast cancer risk from that associated with age at first birth.
The breastfeeding-breast cancer association varied somewhat
by age at menarche and first-degree family history of breast
cancer. The protective effect of longer durations of breastfeeding
was only observed among women who had experienced an older
age at menarche and who had no first-degree family history of
breast cancer. These findings suggest that breastfeeding may be
most protective among women who do not have these well estab-
lished breast cancer risk factors.
The most likely mechanism for its effect on breast cancer risk is
that breastfeeding delays the resumption of ovulation postpartum
(Vorherr, 1973; Gray et al, 1990), reducing a woman's cumulative
number of ovulatory cycles, thereby potentially reducing her risk
of breast cancer (Henderson et al, 1985). The return of regular
ovulatory cycles tends to occur more quickly when the number of
breastfeedings per day is reduced through the use of supplemental
feedings (Stern et al, 1986). As we did not obtain information
about such supplemental feedings, we are unable to evaluate its
impact on our results.
Women who experienced nausea and vomiting in pregnancy
requiring treatment of their symptoms had an increased breast
cancer risk. We previously reported that women with intractable
nausea and vomiting of pregnancy (hyperemesis gravidarum) had,
on average, 26% higher first-trimester serum oestradiol levels than
women who did not vomit during pregnancy, and we hypothesized
that the higher oestrogen exposure may contribute to an increased
breast cancer risk (Depue et al, 1987). When we restricted the
present analysis to women whose most recent pregnancy was
within 5 years of diagnosis, risk was more than twofold higher
among women who had been treated for nausea or vomiting of
pregnancy. We did not obtain information about specific treatment
regimens from the subjects, so we do not know if the observed
association was limited to women receiving specific antiemetic
drugs. However, the observed association probably underestimates
the true risk, because we obtained information only about the most
severe cases ofnausea and vomiting ofpregnancy; the comparison
group undoubtedly included women who experienced some level
of nausea or vomiting during their pregnancies but did not seek
treatment. The association of breast cancer risk with treatment for
nausea or vomiting of pregnancy was considerably weakened
among women whose most recent pregnancy was 5 years or more
before diagnosis. Breastfeeding was only associated with reduced
breast cancer risk among women who were not treated for nausea
and vomiting of pregnancy, regardless of the recency of the
woman's last pregnancy. These findings strongly suggest that the
increase in breast cancer risk associated with severe nausea and
vomiting of pregnancy is transient. This in turn may be due to
hormonally induced differentiation and proliferation ofbreast stem
cells, some of which may have undergone malignant transforma-
tion (Miller, 1993). Breastfeeding appears to protect against breast
cancer in the years immediately following pregnancy, perhaps by
reducing the cyclic hormonal stimulation of breast cells, except
among women who have experienced severe nausea and vomiting
of pregnancy. The excessively elevated oestradiol levels of such
women may irreversibly promote premalignant breast cells but,
further research is needed to confirm this hypothesis.
The use of hormones to suppress lactation was not associated
with risk of breast cancer, similar to the findings of others
(Newcomb et al, 1994). Risk was also not associated with the use
of hormones to induce or promote labour.
In this group of premenopausal women, many of whom were
still bearing children or who had experienced pregnancies in the
recent past, the protective role of breastfeeding and the adverse
role of nausea and vomiting of pregnancy on breast cancer risk
were greatest in the years immediately following pregnancy. These
findings are relevant to the short-term increase in breast cancer
risk following pregnancy. Breastfeeding can be promoted through
the education and support of new mothers and might have an
appreciable impact on future breast cancer incidence.
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